Drug discovery pipelines are notorious for being costly, slow, and failure-prone, leading to AI and machine learning becoming more commonplace to accelerate progress and improve outcomes. Currently, ...
The traditional path of drug development is lengthy, expensive and suffers from high failure rates – scientists test millions of molecules, however, only a handful progress to preclinical or clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results